Table 2.

Multivariate analysis for clinicopathological factors and pathological response after neoadjuvant chemotherapy in GC patients

Factors	Odds ratio (95 % CI)	P
1. Age (years)
≥ 60	1.840 (1.016–3.332)	0.044
< 60	1
2. cT stage
T2	1
T3	0.592 (0.186–1.885)	0.375
T4a	0.419 (0.135–1.294)	0.131
T4b	0.197 (0.032–1.210)	0.079
3. Pathological type
Well-differentiated or moderately differentiated	2.606 (1.321–5.140)	0.006
Poorly differentiated or signet-ring cell	1
4. Weight loss
No weight loss	2.110 (1.161–3.834)	0.014
Weight loss	1

GC gastric cancer, cT stage clinical T stage, CI confidence interval